Sputnik V Provides 90% Protection Against COVID’s Delta Variant
The Sputnik V vaccine provides enough protection against the Delta strain of coronavirus, a leading Russian scientist has said.
That will be welcome news for people in India as it’s the third vaccine approved for use in the country, after Covaxin and Covishield.
“According to data from the UK, the US and other countries, mRNA and vector vaccines, including our Sputnik V, protect against it (Delta variant), albeit to a lesser extent, but they do protect against it. They offered 95 per cent protection against the initial strain and now they give 90% protection against the delta variant,” said Sergey Netesov, head of Novosibirsk State University’s laboratory and member of Russian Academy of Sciences.
He added that the vaccines already developed should be used as they are quite effective.
Two weeks ago, scientist Vladimir Gushchin of Gamaleya National Research Center of Epidemiology and Microbiology – which developed the Sputnik V vaccine – had said that the Russian vaccine guarantees almost 100 per cent protection against severe and fatal cases of COVID-19 caused by Delta variant.
An interim analysis from a trial published in The Lancet said that Sputnik V has 91.6 per cent efficacy, while Gamaleya National Research Center and Russian Direct Investment Fund have reported that the vaccine has 97.6 per cent efficacy.
Russia was the world’s first country to register a coronavirus vaccine, Sputnik V, in August 2020.